InvestorsHub Logo
Followers 19
Posts 901
Boards Moderated 0
Alias Born 05/31/2013

Re: None

Wednesday, 03/21/2018 9:57:57 AM

Wednesday, March 21, 2018 9:57:57 AM

Post# of 48316
Lotta good people been here a long time--My "alias born" date is "05/31/2013 01:25:37 PM" but even that was update from Waitforit52. I was going to update it for every year I aged, of which I am 58 now.

I have for ever felt like I have been on OncoSec Airlines with some of you guys ever taxiing at OncoSec Airlines here in Chicago, passing runway after runway...then waiting in line to take off, only to be redirected to another runway to wait in line again.

Gotta admit though, it is looking like the ImmunoPulse aircraft we are on is beginning to accelerate toward take-off sometime over the next 5 months? What looks like what will provide sufficient thrust is a combination of TNBC data and trial advancement, Pisces data with potential licensing/partnering -- Not to mention the possibility of a Buyout.

But I would love a discussion on not just Pros and possibilities with well estimated projected $ potential, but also potential cons and delayed and/or prolonged development and estimated downside $ potential.

There are some new irons in the fire--Multi-gene, and small synthetic anti-PDL-1, not to mention all the other indications that can now be reached with the New and Improved electroporator which is less painful and capable of subcutaneous tumor treatment with sophisticated drug uptake measuring for more on-the-spot accurate dosing.

Whatchuguys think?